Showing results (31-40 of 213) with videos related to
Sort By:
Pageof 22
The Journal of General Virology|October 13, 2006
Matrix protein of Vesicular stomatitis virus harbours a cryptic mitochondrial-targeting motifBrian D Lichty, Heidi McBride, Stephen Hanson, et al.Molecular Therapy : the Journal of the American Society of Gene Therapy|April 21, 2011
Thunder and lightning: immunotherapy and oncolytic viruses collideAlan Melcher, Kelley Parato, Cliona M Rooney, et al.Immunobiology|December 19, 2007
Matrix protein mediated shutdown of host cell metabolism limits vesicular stomatitis virus-induced interferon-alpha responses to plasmacytoid dendritic cellsZoe Waibler, Claudia N Detje, John C Bell, et al.Current Opinion in Molecular Therapeutics|January 30, 2008
Innate immunity, tumor microenvironment and oncolytic virus therapy: friends or foes?Marianne M Stanford, Caroline J Breitbach, John C Bell, et al.Molecular Therapy Oncolytics|June 14, 2019
An Oncolytic Adenovirus Vector Expressing p14 FAST Protein Induces Widespread Syncytium Formation and Reduces Tumor Growth Rate In VivoJosh Del Papa, Julia Petryk, John C Bell, et al.Cytokine & Growth Factor Reviews|March 12, 2010
Novel oncolytic viruses: riding high on the next wave?Marianne M Stanford, John C Bell, Markus J V Vähä-KoskelaCommunications Medicine|May 23, 2022
Advances in oncolytic virotherapyStephen J Russell, John C Bell, Christine E Engeland, et al.Molecular Therapy : the Journal of the American Society of Gene Therapy|March 3, 2011
Targeting tumor vasculature with an oncolytic virusCaroline J Breitbach, Naomi S De Silva, Theresa J Falls, et al.Expert Opinion on Biological Therapy|April 17, 2020
Engineering vaccinia virus as an immunotherapeutic battleship to overcome tumor heterogeneityAdrian Pelin, Stephen Boulton, Levi A Tamming, et al.Nature Reviews. Cancer|November 19, 2005
Recent progress in the battle between oncolytic viruses and tumoursKelley A Parato, Donna Senger, Peter A J Forsyth, et al.Pageof 22